Does LINACLOTIDE Cause Malignant neoplasm progression? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Malignant neoplasm progression have been filed in association with LINACLOTIDE (Linzess). This represents 0.1% of all adverse event reports for LINACLOTIDE.
8
Reports of Malignant neoplasm progression with LINACLOTIDE
0.1%
of all LINACLOTIDE reports
4
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From LINACLOTIDE?
Of the 8 reports, 4 (50.0%) resulted in death, 2 (25.0%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LINACLOTIDE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LINACLOTIDE Cause?
Diarrhoea (3,638)
Drug ineffective (3,560)
Off label use (2,634)
Constipation (1,123)
Abdominal distension (861)
Abdominal pain (674)
Abdominal pain upper (571)
Flatulence (554)
Inappropriate schedule of product administration (547)
Intentional product misuse (462)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which LINACLOTIDE Alternatives Have Lower Malignant neoplasm progression Risk?
LINACLOTIDE vs LINAGLIPTIN
LINACLOTIDE vs LINAGLIPTIN\METFORMIN
LINACLOTIDE vs LINCOMYCIN
LINACLOTIDE vs LINEZOLID
LINACLOTIDE vs LINZESS